Literature DB >> 9786023

Modulation of opioid analgesia, tolerance and dependence by Gs-coupled, GM1 ganglioside-regulated opioid receptor functions.

S M Crain1, K F Shen.   

Abstract

Studies of direct excitatory effects elicited by opioid agonists on various types of neurone have been confirmed and expanded in numerous laboratories following the initial findings reviewed previously by Stanley Crain and Ke-Fei Shen. However, the critical role of the endogenous glycolipid GM1 ganglioside in regulating Gs-coupled, excitatory opioid receptor functions has not been addressed in any of the recent reviews of opioid stimulatory mechanisms. This article by Stanley Crain and Ke-Fei Shen focuses on crucial evidence that the concentration of GM1 in neurones might, indeed, play a significant role in the modulation of opioid receptor-mediated analgesia, tolerance and dependence.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9786023     DOI: 10.1016/s0165-6147(98)01241-3

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  23 in total

1.  Involvement of opioid receptor subtypes in both stimulatory and inhibitory effects of the opioid peptides on prolactin secretion during pregnancy.

Authors:  M Soaje; R P Deis
Journal:  Cell Mol Neurobiol       Date:  2004-04       Impact factor: 5.046

2.  Contribution of adrenomedullin to the switch of G protein-coupled μ-opioid receptors from Gi to Gs in the spinal dorsal horn following chronic morphine exposure in rats.

Authors:  Dongmei Wang; Juan Zeng; Qi Li; Jianzhong Huang; Réjean Couture; Yanguo Hong
Journal:  Br J Pharmacol       Date:  2016-02-25       Impact factor: 8.739

3.  Intrathecal PKA-selective siRNA treatment blocks sustained morphine-mediated pain sensitization and antinociceptive tolerance in rats.

Authors:  S Tumati; W R Roeske; T M Largent-Milnes; T W Vanderah; E V Varga
Journal:  J Neurosci Methods       Date:  2011-05-06       Impact factor: 2.390

Review 4.  The use of opioids in cancer patients with renal impairment-a systematic review.

Authors:  Tonje A Sande; Barry J A Laird; Marie T Fallon
Journal:  Support Care Cancer       Date:  2016-10-15       Impact factor: 3.603

5.  [Opioid-induced analgesia and hyperalgesia].

Authors:  W Koppert
Journal:  Schmerz       Date:  2005-10       Impact factor: 1.107

Review 6.  The role of sphingolipids in psychoactive drug use and addiction.

Authors:  Liubov S Kalinichenko; Erich Gulbins; Johannes Kornhuber; Christian P Müller
Journal:  J Neural Transm (Vienna)       Date:  2018-01-10       Impact factor: 3.575

Review 7.  Pain management in the critically ill child.

Authors:  M Yaster; D G Nichols
Journal:  Indian J Pediatr       Date:  2001-08       Impact factor: 1.967

8.  A novel alternatively spliced isoform of the mu-opioid receptor: functional antagonism.

Authors:  Pavel Gris; Josee Gauthier; Philip Cheng; Dustin G Gibson; Denis Gris; Oskar Laur; John Pierson; Sean Wentworth; Andrea G Nackley; William Maixner; Luda Diatchenko
Journal:  Mol Pain       Date:  2010-06-02       Impact factor: 3.395

9.  Supraspinal Gbetagamma-dependent stimulation of PLCbeta originating from G inhibitory protein-mu opioid receptor-coupling is necessary for morphine induced acute hyperalgesia.

Authors:  Enrica Bianchi; Monica Norcini; Alan Smrcka; Carla Ghelardini
Journal:  J Neurochem       Date:  2009-07-27       Impact factor: 5.372

10.  Pilot study of continuous co-infusion of morphine and naloxone in children with sickle cell pain crisis.

Authors:  Josh Koch; Renee Manworren; Lynn Clark; Charles T Quinn; George R Buchanan; Zora R Rogers
Journal:  Am J Hematol       Date:  2008-09       Impact factor: 10.047

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.